Results
216
Companies which are more than 50% undervalued based on analyst price target.
216 companies
AOTI
Market Cap: UK£64.0m
Produces, rents, and sells medical devices to resolve severe acute and chronic wounds for customers worldwide.
AOTI
UK£0.55
7D
0%
1Y
-59.3%
Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi
Market Cap: ₺3.5b
Manufactures and sells medical devices in Turkey.
MEDTR
₺29.40
7D
-3.4%
1Y
-26.8%
IceCure Medical
Market Cap: US$83.4m
A commercial stage medical device company, researches, develops, and markets cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally.
ICCM
US$1.03
7D
-8.0%
1Y
64.5%
Vivani Medical
Market Cap: US$81.2m
A clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases.
VANI
US$1.29
7D
12.2%
1Y
10.3%
Xtant Medical Holdings
Market Cap: US$79.5m
Provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally.
XTNT
US$0.63
7D
-1.4%
1Y
11.5%
Apyx Medical
Market Cap: US$77.5m
An energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally.
APYX
US$1.96
7D
-1.5%
1Y
50.8%
Kooth
Market Cap: UK£54.7m
Provides digital mental health services to children, young people, and adults in the United Kingdom.
KOO
UK£1.52
7D
-3.5%
1Y
-51.6%
Sequana Medical
Market Cap: €62.2m
Develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, and internationally.
SEQUA
€1.06
7D
7.2%
1Y
14.7%
Pulmonx
Market Cap: US$70.9m
A commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease.
LUNG
US$1.74
7D
1.8%
1Y
-76.2%
Creo Medical Group
Market Cap: UK£52.3m
Through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom.
CREO
UK£0.13
7D
-1.9%
1Y
-55.2%
VolitionRx
Market Cap: US$68.3m
A multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia.
VNRX
US$0.60
7D
-12.8%
1Y
-13.7%
Ray
Market Cap: ₩93.5b
RAY Co., Ltd. provides x-ray diagnostic equipment in the dental industry.
A228670
₩5,990.00
7D
-1.6%
1Y
-24.8%
Forian
Market Cap: US$66.9m
Provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the life science, healthcare, and financial services industries.
FORA
US$2.10
7D
6.6%
1Y
-10.6%
Affluent Medical
Market Cap: €57.1m
A medical technology company, develops and markets minimally invasive minimally invasive medical devices in the field of urology and structural heart in France.
AFME
€1.45
7D
-10.5%
1Y
-22.9%
Modulight Oyj
Market Cap: €55.7m
Designs, manufactures, and markets lasers products for medical and other diagnostic applications.
MODU
€1.31
7D
-2.1%
1Y
13.1%
Biodesix
Market Cap: US$65.0m
Operates as a diagnostic solutions company.
BDSX
US$0.44
7D
3.5%
1Y
-76.1%
Cyclopharm
Market Cap: AU$96.7m
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally.
CYC
AU$0.87
7D
-11.7%
1Y
-42.0%
TELA Bio
Market Cap: US$63.0m
A commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy.
TELA
US$1.59
7D
-10.7%
1Y
-42.2%
P3 Health Partners
Market Cap: US$63.0m
A patient-centered and physician-led population health management company, provides superior care services in the United States.
PIII
US$8.77
7D
5.3%
1Y
-61.9%
Fractyl Health
Market Cap: US$62.4m
A metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity.
GUTS
US$0.92
7D
-5.0%
1Y
-70.5%
Odysight.ai
Market Cap: US$61.8m
Develops, produces, and markets visualization AI solutions in Israel, the United States, and internationally.
ODYS
US$3.78
7D
-3.8%
1Y
-33.7%
Cytosorbents
Market Cap: US$61.2m
Engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally.
CTSO
US$0.97
7D
2.4%
1Y
-6.3%
Daxor
Market Cap: US$56.5m
A medical device company, provides blood volume measurement technology focused on blood volume testing.
DXR
US$11.06
7D
0.5%
1Y
27.1%
Rockwell Medical
Market Cap: US$55.8m
Develops, manufactures, commercializes, and distributes various hemodialysis products for dialysis providers worldwide.
RMTI
US$1.62
7D
-5.3%
1Y
-45.6%
CM Hospitalar S/A
Market Cap: R$287.4m
Engages in the distribution of hospital materials, medicines, and nutrition products in Brazil.
VVEO3
R$0.91
7D
2.2%
1Y
-55.0%
Sensus Healthcare
Market Cap: US$52.3m
Operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide.
SRTS
US$3.23
7D
-4.7%
1Y
-41.5%
ImpediMed
Market Cap: AU$79.4m
A medical technology company, develops, manufactures and sells bioimpedance spectroscopy (BIS) technology medical devices and software services in the Unites States, Europe and Australia.
IPD
AU$0.039
7D
0%
1Y
-18.8%
Svas Biosana
Market Cap: €43.0m
SVAS Biosana S.p.A. engages in the production and marketing of medical devices worldwide.
SVS
€8.10
7D
-1.2%
1Y
5.2%
Spectral AI
Market Cap: US$48.9m
An artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States.
MDAI
US$1.82
7D
-5.7%
1Y
35.8%
Pentixapharm Holding
Market Cap: €41.6m
A clinical-stage biopharmaceutical company, develops radiopharmaceuticals.
PTP
€1.68
7D
-3.8%
1Y
n/a
Milestone Scientific
Market Cap: US$48.7m
A biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally.
MLSS
US$0.62
7D
4.6%
1Y
-40.1%
Mach7 Technologies
Market Cap: AU$74.0m
Develops and commercializes medical imaging and data management software solutions for healthcare organizations in North America, the Asia Pacific, the Middle East, Europe, and internationally.
M7T
AU$0.32
7D
0%
1Y
-43.8%
HeartBeam
Market Cap: US$48.0m
Operates as a medical technology company that focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting.
BEAT
US$1.35
7D
0%
1Y
-41.6%
Zynex
Market Cap: US$45.1m
Designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation.
ZYXI
US$1.49
7D
-9.1%
1Y
-81.0%
Beamtree Holdings
Market Cap: AU$68.3m
Provides artificial intelligence-based decision support software and data insight solutions, and other software services to the healthcare industry in Australia and internationally.
BMT
AU$0.23
7D
0%
1Y
-19.7%
BlinkLab
Market Cap: AU$65.1m
Focuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing.
BB1
AU$0.52
7D
-8.8%
1Y
136.4%